Perceptive Advisors - AMYLYX PHARMACEUTICALS INC ownership

AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 83 filers reported holding AMYLYX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Perceptive Advisors ownership history of AMYLYX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$49,233,265
-53.2%
2,688,873
-44.8%
1.64%
-46.0%
Q2 2023$105,130,433
-40.6%
4,873,919
-19.2%
3.04%
-41.8%
Q1 2023$177,056,455
-21.3%
6,034,644
-0.9%
5.23%
-17.2%
Q4 2022$224,963,904
+46.0%
6,088,333
+11.3%
6.32%
+41.3%
Q3 2022$154,038,000
+125.9%
5,472,033
+54.6%
4.47%
+109.3%
Q2 2022$68,188,000
+260.0%
3,540,408
+140.2%
2.14%
+463.6%
Q1 2022$18,942,0001,474,1070.38%
Other shareholders
AMYLYX PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 2,515,868$46,065,54315.30%
Alpha Wave Global, LP 853,262$15,623,2279.88%
Saturn V Capital Management LP 886,143$16,225,2786.79%
Ally Bridge Group (NY) LLC 272,690$4,992,9545.86%
Altium Capital Management LP 534,700$9,790,3575.11%
Boxer Capital, LLC 2,084,000$38,158,0402.03%
Octagon Capital Advisors LP 695,000$12,725,4501.96%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 295,000$5,398,5001.82%
Tri Locum Partners LP 282,862$5,179,2031.66%
Perceptive Advisors 2,688,873$49,233,2651.64%
View complete list of AMYLYX PHARMACEUTICALS INC shareholders